H11 kinase is the eukaryotic homologue of ICP10 protein kinase, a Ras-GAP kinase from Herpes Simplex required for virus growth. In normal tissues, H11 kinase expression is restricted to the heart and skeletal muscle. Although its function remains unknown, H11 kinase probably participates in mechanisms of cell growth because its induction in non-muscular cells promotes transformation into cancer cells. Putative interactions include the nuclear casein kinase II (NUCKS II), a stimulator of cell growth, the protein HSP27, a stimulator of cell survival, and the nucleosome assembly protein-1 (NAP-l), a stimulator of cell proliferation. By subtractive hybridization, we unexpectedly found that H11 kinase transcript and protein are upregulated in large mammalian models of reversible ischemia/reperfusion and chronic left ventricular hypertrophy. Our preliminary data show that overexpression of H11 kinase in isolated cardiac myocytes promotes cell growth. A cardiac-specific transgenic mouse has been generated, which confirms that overexpression of H11 kinase induces cardiac hypertrophy and protects against cell death during ischemia/reperfusion in vivo. Based on these observations, the overall goal of this proposal is to determine the physiological role, signaling mechanisms and functional importance of H11 kinase in the myocardium. The first specific aim is to determine in vivo the functional and genomic effects of H11 kinase overexpression in a cardiac-specific transgenic mouse model submitted to transverse aortic banding or ischemia/reperfusion. We hypothesize that H11 kinase overexpression in transgenic mice will decrease irreversible cellular damage in hypertrophied and ischemic hearts.
The second aim i s to determine the signaling pathways in which H11 kinase is integrated. We hypothesize that H11 kinase promotes cardiac growth and survival by stimulating NUCKS II, HSP27 and NAP-l, but that other unexpected proteins might interact as well.
The third aim i s to show, both in vitro with a dominant negative and in vivo in a knock-out model, that H11 kinase represents an essential pathway of cardiac growth and survival. We hypothesize that the tissue-restricted expression of H11 kinase underlies a specific signaling pathway that is not dispensable for normal cardiac cell growth. These experiments will unravel novel mechanisms and signaling pathways of cardiac growth, which may result in new therapeutic avenues for both ischemic heart disease and heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL072863-03
Application #
6979775
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Buxton, Denis B
Project Start
2003-12-01
Project End
2007-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2006
Total Cost
$379,614
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
623946217
City
Newark
State
NJ
Country
United States
Zip Code
07107
Qiu, Hongyu; Lizano, Paulo; Laure, Lydie et al. (2011) H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of STAT3 and accelerates the transition into heart failure on cardiac overload. Circulation 124:406-15
Chen, Li; Lizano, Paulo; Zhao, Xin et al. (2011) Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol 300:H1303-10
Hedhli, Nadia; Depre, Christophe (2010) Proteasome inhibitors and cardiac cell growth. Cardiovasc Res 85:321-9
Li, Dan; Depre, Christophe (2010) Ubiquitin, a novel paracrine messenger of cardiac cell survival. Cardiovasc Res 86:1-3
Sui, Xiangzhen; Li, Dan; Qiu, Hongyu et al. (2009) Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival. Circ Res 104:887-95
Hedhli, Nadia; Lizano, Paulo; Hong, Chull et al. (2008) Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol 295:H1385-93
Hedhli, Nadia; Wang, Li; Wang, Qian et al. (2008) Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22. Cardiovasc Res 77:497-505
Depre, Christophe; Vatner, Stephen F (2007) Cardioprotection in stunned and hibernating myocardium. Heart Fail Rev 12:307-17
Qiu, Hongyu; Tian, Bin; Resuello, Ranilo G et al. (2007) Sex-specific regulation of gene expression in the aging monkey aorta. Physiol Genomics 29:169-80
Depre, Christophe; Wang, Li; Sui, Xiangzhen et al. (2006) H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart. Circ Res 98:280-8

Showing the most recent 10 out of 13 publications